208 results on '"Neil, M. A. A."'
Search Results
2. Impact of Availability of Anti–Vascular Endothelial Growth Factor Therapy on Visual Impairment and Blindness Due to Neovascular Age-Related Macular Degeneration
3. Evaluation of Masking Study Participants to Intravitreal Injections in a Randomized Clinical Trial
4. Understanding and Reporting Visual Acuity Measurements in Publications of Clinical Research
5. Frequency of Intraocular Pressure Increase Within Days After Intravitreal Triamcinolone Injections in the Diabetic Retinopathy Clinical Research Network
6. Estimated Cases of Legal Blindness and Visual Impairment Avoided Using Ranibizumab for Choroidal Neovascularization: Non-Hispanic White Population in the United States With Age-Related Macular Degeneration
7. Patient-Reported Outcomes Among Sham vs No-Treatment Controls From Randomized Trials
8. Topical Antibiotics to Reduce the Risk of Endophthalmitis After Intravitreal Injection?—Reply
9. The Use of Sham Controls in Clinical Trials—Reply
10. Exploratory Analysis of Diabetic Retinopathy Progression Through 3 Years in a Randomized Clinical Trial That Compares Intravitreal Triamcinolone Acetonide With Focal/Grid Photocoagulation
11. Risk of Endophthalmitis After Intravitreal Drug Injection When Topical Antibiotics Are Not Required: The Diabetic Retinopathy Clinical Research Network Laser-Ranibizumab-Triamcinolone Clinical Trials
12. Progression of Age-Related Macular Degeneration After Cataract Surgery
13. Visual Acuity Outcomes Among Sham vs No-Treatment Controls From Randomized Trials
14. Improved Vision-Related Function After Ranibizumab vs Photodynamic Therapy: A Randomized Clinical Trial
15. Three-year follow-up of a randomized trial comparing focal/grid photocoagulation and intravitreal triamcinolone for diabetic macular edema
16. Improved Vision-Related Function After Ranibizumab Treatment of Neovascular Age-Related Macular Degeneration: Results of a Randomized Clinical Trial
17. Retinal Anastomosis to Choroidal Neovascularization: A Bum Rap for a Difficult Disease
18. Photodynamic Therapy With Verteporfin: Observations on the Introduction of a New Treatment Into Clinical Practice
19. Choroidal Neovascularization After Central Retinal Vein Occlusion in a 47-Year-Old Man
20. Histopathologic and ultrastructural features of surgically excised subfoveal choroidal neovascular lesions: Submacular Surgery Trials Report No. 7
21. Advantages and Potential Dangers of Presentation Before Publication: Third in a Series on Editorship
22. Relative Contributions of Reduced Vision and General Health to NEI-VFQ Scores in Patients With Neovascular Age-Related Macular Degeneration
23. Natural History of Minimally Classic Subfoveal Choroidal Neovascular Lesions in the Treatment of Age-Related Macular Degeneration With Photodynamic Therapy (TAP) Investigation: Outcomes Potentially Relevant to Management—TAP Report No.6
24. Detection of Diabetic Foveal Edema: Contact Lens Biomicroscopy Compared With Optical Coherence Tomography
25. Health and Vision Related Quality of Life Among Patients with Ocular Histoplasmosis or Idiopathic Choroidal Neovascularization at Enrollment in a Randomized Trial of Submacular Surgery
26. Use of Best and Final Visual Acuity Outcomes in Ophthalmological Research
27. Retinal Pigment Epithelium Tumorlike Lesion Arising From an Area Treated With Laser Photocoagulation
28. Retinal Arteriolar Narrowing and Risk of Coronary Heart Disease
29. Potential public health impact of age-related eye disease study results: AREDS report no. 11
30. Apparent Disappearance of Choroidal Neovascularization After Initial Photodynamic Therapy With Verteporfin
31. Verteporfin therapy for subfoveal choroidal neovascularization in age-related macular degeneration: three-year results of an open-label extension of 2 randomized clinical trials - TAP Report No. 5
32. Retinopathy in Patients With Type 1 Diabetes 4 Years After Intensive Therapy
33. A Preliminary Study of Photodynamic Therapy Using Verteporfin for Choroidal Neovascularization in Pathologic Myopia, Ocular Histoplasmosis Syndrome, Angioid Streaks, and Idiopathic Causes
34. Photodynamic Therapy With Verteporfin for Choroidal Neovascularization Caused by Age-related Macular Degeneration: Results of a Single Treatment in a Phase 1 and 2 Study
35. Photodynamic Therapy With Verteporfin for Choroidal Neovascularization Caused by Age-related Macular Degeneration: Results of Retreatments in a Phase 1 and 2 Study
36. Evaluating New Retinal Imaging Techniques
37. Reviewers, Authors, and Editors: Balance of Power
38. Availability of Color Fundus Photographs From Previous Visit Affects Practice Patterns for Patients With Diabetes Mellitus
39. Evaluating New Retinal Imaging Techniques
40. Submacular Surgery: New Information, More Questions
41. Occult Choroidal Neovascularization in Age-Related Macular Degeneration: A Natural History Study
42. Macular Scatter ('Grid') Laser Treatment of Poorly Demarcated Subfoveal Choroidal Neovascularization in Age-Related Macular Degeneration: Results of a Randomized Pilot Trial
43. Meeting Report of the Hawaii '96 Meeting, Grand Wailea, January 21-26, 1996
44. Indocyanine Green Angiography: Can It Help Preserve the Vision of Our Patients?
45. Cigarette Smoking and Risk for Progression of Nuclear Opacities
46. Sudden Visual Loss Associated With Sexual Activity
47. Five-Year Incidence and Disappearance of Drusen and Retinal Pigment Epithelial Abnormalities: Waterman Study
48. Topical antibiotics to reduce the risk of endophthalmitis after intravitreal injection?
49. Industry funding for continuing medical education: is it ethical?
50. The use of sham controls in clinical trials
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.